XERIS PHARMACEUTICALS INC (23) | Business Finance (12)

Browse by Subcategory

Recent Contracts

Form of Securities Purchase Agreement (Filed With SEC on March 11, 2021)
Fourth Amendment to Amended and Restated Loan and Security Agreement, dated as of October 23, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on March 9, 2021)
Form of Exchange Agreement (Filed With SEC on November 16, 2020)
Base Indenture, dated as of June 30, 2020, by and between Xeris Pharmaceuticals, Inc. and U.S. Bank National Association (Filed With SEC on July 1, 2020)
U.S. Small Business Administration Paycheck Protection Program Note, entered into April 21, 2020 by the Company (Filed With SEC on April 24, 2020)
Underwriting Agreement, dated February 11, 2020, by and among Xeris Pharmaceuticals, Inc., Jefferies LLC and Piper Sandler & Co (Filed With SEC on February 13, 2020)
Third Amendment to Amended and Restated Loan and Security Agreement, dated as of August 5, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on November 9, 2020)
Second Amendment to Amended and Restated Loan and Security Agreement, dated as of June 30, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Company (Filed With SEC on August 10, 2020)
First Amendment to Amended and Restated Loan and Security Agreement, dated April 21, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Company (Filed With SEC on May 7, 2020)
Amended and Restated Loan and Security Agreement, dated as of September 10, 2019, by and between Oxford Finance LLC, Silicon Valley Bank and Xeris Pharmaceuticals, Inc (Filed With SEC on September 10, 2019)
Second Amendment to Loan and Security Agreement, dated as of May 15, 2019, by and among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on August 6, 2019)
Form of Underwriting Agreement (Filed With SEC on February 11, 2019)